Selected research
Industry Research
Anticoccidial Drugs Industry Research Report 2026
Market perspective
The global Anticoccidial Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Anticoccidial Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Anticoccidial Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Anticoccidial Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Anticoccidial Drugs include Zoetis, Novartis Animal Healthcare, Virbac, Merial, Jurox, Intas, Dosch Pharma, Ceva Santé Animale and Boehringer Ingelheim, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Anticoccidial Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Anticoccidial Drugs Market by Company
Zoetis
Novartis Animal Healthcare
Virbac
Merial
Jurox
Intas
Dosch Pharma
Ceva Santé Animale
Boehringer Ingelheim
Biopredic
Anticoccidial Drugs Segment by Type
Chemical Derivative Anticoccidials
Antibiotic Anticoccidials
Ionophore Anticoccidials
Anticoccidial Drugs Segment by Application
Swine
Fish
Poultry
Cattle
Companion Animals
Anticoccidial Drugs Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anticoccidial Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anticoccidial Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anticoccidial Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Anticoccidial Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Anticoccidial Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Anticoccidial Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Chemical Derivative Anticoccidials
- Antibiotic Anticoccidials
- Ionophore Anticoccidials
Applications
- Swine
- Fish
- Poultry
- Cattle
- Companion Animals
Companies covered
- Zoetis
- Novartis Animal Healthcare
- Virbac
- Merial
- Jurox
- Intas
- Dosch Pharma
- Ceva Santé Animale
- Boehringer Ingelheim
- Biopredic
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Anticoccidial Drugs Market Size (2021-2032)
- 2.2.2 Global Anticoccidial Drugs Sales (2021-2032)
- 2.2.3 Global Anticoccidial Drugs Market Average Price (2021-2032)
- 2.3 Anticoccidial Drugs by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Chemical Derivative Anticoccidials
- 2.3.3 Antibiotic Anticoccidials
- 2.3.4 Ionophore Anticoccidials
- 2.4 Anticoccidial Drugs by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Swine
- 2.4.3 Fish
- 2.4.4 Poultry
- 2.4.5 Cattle
- 2.4.6 Companion Animals
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Anticoccidial Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Anticoccidial Drugs Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Anticoccidial Drugs Revenue of Manufacturers (2021-2026)
- 3.4 Global Anticoccidial Drugs Average Price by Manufacturers (2021-2026)
- 3.5 Global Anticoccidial Drugs Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Anticoccidial Drugs, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Anticoccidial Drugs, Product Type & Application
- 3.8 Global Manufacturers of Anticoccidial Drugs, Established Date
- 3.9 Global Anticoccidial Drugs Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Zoetis
- 4.1.1 Zoetis Company Information
- 4.1.2 Zoetis Business Overview
- 4.1.3 Zoetis Anticoccidial Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Zoetis Anticoccidial Drugs Product Portfolio
- 4.1.5 Zoetis Recent Developments
- 4.2 Novartis Animal Healthcare
- 4.2.1 Novartis Animal Healthcare Company Information
- 4.2.2 Novartis Animal Healthcare Business Overview
- 4.2.3 Novartis Animal Healthcare Anticoccidial Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Novartis Animal Healthcare Anticoccidial Drugs Product Portfolio
- 4.2.5 Novartis Animal Healthcare Recent Developments
- 4.3 Virbac
- 4.3.1 Virbac Company Information
- 4.3.2 Virbac Business Overview
- 4.3.3 Virbac Anticoccidial Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Virbac Anticoccidial Drugs Product Portfolio
- 4.3.5 Virbac Recent Developments
- 4.4 Merial
- 4.4.1 Merial Company Information
- 4.4.2 Merial Business Overview
- 4.4.3 Merial Anticoccidial Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Merial Anticoccidial Drugs Product Portfolio
- 4.4.5 Merial Recent Developments
- 4.5 Jurox
- 4.5.1 Jurox Company Information
- 4.5.2 Jurox Business Overview
- 4.5.3 Jurox Anticoccidial Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Jurox Anticoccidial Drugs Product Portfolio
- 4.5.5 Jurox Recent Developments
- 4.6 Intas
- 4.6.1 Intas Company Information
- 4.6.2 Intas Business Overview
- 4.6.3 Intas Anticoccidial Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Intas Anticoccidial Drugs Product Portfolio
- 4.6.5 Intas Recent Developments
- 4.7 Dosch Pharma
- 4.7.1 Dosch Pharma Company Information
- 4.7.2 Dosch Pharma Business Overview
- 4.7.3 Dosch Pharma Anticoccidial Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Dosch Pharma Anticoccidial Drugs Product Portfolio
- 4.7.5 Dosch Pharma Recent Developments
- 4.8 Ceva Santé Animale
- 4.8.1 Ceva Santé Animale Company Information
- 4.8.2 Ceva Santé Animale Business Overview
- 4.8.3 Ceva Santé Animale Anticoccidial Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Ceva Santé Animale Anticoccidial Drugs Product Portfolio
- 4.8.5 Ceva Santé Animale Recent Developments
- 4.9 Boehringer Ingelheim
- 4.9.1 Boehringer Ingelheim Company Information
- 4.9.2 Boehringer Ingelheim Business Overview
- 4.9.3 Boehringer Ingelheim Anticoccidial Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Boehringer Ingelheim Anticoccidial Drugs Product Portfolio
- 4.9.5 Boehringer Ingelheim Recent Developments
- 4.10 Biopredic
- 4.10.1 Biopredic Company Information
- 4.10.2 Biopredic Business Overview
- 4.10.3 Biopredic Anticoccidial Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Biopredic Anticoccidial Drugs Product Portfolio
- 4.10.5 Biopredic Recent Developments
5 Global Anticoccidial Drugs Market Scenario by Region
- 5.1 Global Anticoccidial Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Anticoccidial Drugs Sales by Region: 2021-2032
- 5.2.1 Global Anticoccidial Drugs Sales by Region: 2021-2026
- 5.2.2 Global Anticoccidial Drugs Sales by Region: 2027-2032
- 5.3 Global Anticoccidial Drugs Revenue by Region: 2021-2032
- 5.3.1 Global Anticoccidial Drugs Revenue by Region: 2021-2026
- 5.3.2 Global Anticoccidial Drugs Revenue by Region: 2027-2032
- 5.4 North America Anticoccidial Drugs Market Facts & Figures by Country
- 5.4.1 North America Anticoccidial Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Anticoccidial Drugs Sales by Country (2021-2032)
- 5.4.3 North America Anticoccidial Drugs Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Anticoccidial Drugs Market Facts & Figures by Country
- 5.5.1 Europe Anticoccidial Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Anticoccidial Drugs Sales by Country (2021-2032)
- 5.5.3 Europe Anticoccidial Drugs Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Anticoccidial Drugs Market Facts & Figures by Country
- 5.6.1 Asia Pacific Anticoccidial Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Anticoccidial Drugs Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Anticoccidial Drugs Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Anticoccidial Drugs Market Facts & Figures by Country
- 5.7.1 South America Anticoccidial Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Anticoccidial Drugs Sales by Country (2021-2032)
- 5.7.3 South America Anticoccidial Drugs Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Anticoccidial Drugs Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Anticoccidial Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Anticoccidial Drugs Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Anticoccidial Drugs Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Anticoccidial Drugs Sales by Type (2021-2032)
- 6.1.1 Global Anticoccidial Drugs Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Anticoccidial Drugs Sales Market Share by Type (2021-2032)
- 6.2 Global Anticoccidial Drugs Revenue by Type (2021-2032)
- 6.2.1 Global Anticoccidial Drugs Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Anticoccidial Drugs Revenue Market Share by Type (2021-2032)
- 6.3 Global Anticoccidial Drugs Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Anticoccidial Drugs Sales by Application (2021-2032)
- 7.1.1 Global Anticoccidial Drugs Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Anticoccidial Drugs Sales Market Share by Application (2021-2032)
- 7.2 Global Anticoccidial Drugs Revenue by Application (2021-2032)
- 7.2.1 Global Anticoccidial Drugs Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Anticoccidial Drugs Revenue Market Share by Application (2021-2032)
- 7.3 Global Anticoccidial Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Anticoccidial Drugs Value Chain Analysis
- 8.1.1 Anticoccidial Drugs Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Anticoccidial Drugs Production Mode & Process
- 8.2 Anticoccidial Drugs Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Anticoccidial Drugs Distributors
- 8.2.3 Anticoccidial Drugs Customers
9 Global Anticoccidial Drugs Analyzing Market Dynamics
- 9.1 Anticoccidial Drugs Industry Trends
- 9.2 Anticoccidial Drugs Industry Drivers
- 9.3 Anticoccidial Drugs Industry Opportunities and Challenges
- 9.4 Anticoccidial Drugs Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst